Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology von Jardim, Denis L., de Melo Gagliato, Débora, Kurzrock, Razelle

Volltext

Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2− advanced breast cancer: a Brazilian public health care system perspective von Rosa, Daniela Dornelles, Magliano, Carlos Alberto da Silva, Simon, Sergio D., Amorim, Gilberto, Reinert, Tomás, Landeiro, Luciana, Gagliato, Débora de Melo, Exman, Pedro, Argolo, Daniel, Guilgen, Gisah, Mano, Max, Testa, Laura, Liedke, Pedro, Barroso, Romualdo, Sasse, Mariana, Buehler, Anna Maria

Volltext

Analysis of Drug Development Paradigms for Immune Checkpoint Inhibitors von Jardim, Denis L, de Melo Gagliato, Débora, Giles, Francis J, Kurzrock, Razelle

Volltext

Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds von Jardim, Denis L., De Melo Gagliato, Débora, Nikanjam, Mina, Barkauskas, Donald A., Kurzrock, Razelle

Volltext

Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer von Bonadio, Renata Colombo, de Sousa, Isadora Martins, Balint, Flávia Cavalcanti, Comini, Ana Carolina Marin, Tavares, Monique Celeste, Madasi, Fernanda, Bines, Jose, Ferreira, Rafael Dal Ponte, Rosa, Daniela Dornelles, Santos, Candice Lima, de Souza, Zenaide Silva, Assad-Suzuki, Daniele, de Araújo, Júlio Antônio Pereira, Gagliato, Débora de Melo, dos Anjos, Carlos Henrique, Zucchetti, Bruna M., Ferrari, Anezka, de Brito, Mayana Lopes, Cangussu, Renata, Monteiro, Maria Marcela Fernandes, Hoff, Paulo M., Testa, Laura, Barroso-Sousa, Romualdo

Volltext

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker von Jardim, Denis L., Goodman, Aaron, de Melo Gagliato, Debora, Kurzrock, Razelle

Volltext

Delays in Adjuvant Chemotherapy Among Breast Cancer Patients: An Unintended Consequence of Breast Surgery? von de Melo Gagliato, Debora, Chavez-MacGregor, Mariana

Volltext

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic von Jardim, Denis L F, Tang, Chad, Gagliato, Debora De Melo, Falchook, Gerald S, Hess, Kenneth, Janku, Filip, Fu, Siqing, Wheler, Jennifer J, Zinner, Ralph G, Naing, Aung, Tsimberidou, Apostolia M, Holla, Vijaykumar, Li, Marylin M, Roy-Chowdhuri, Sinchita, Luthra, Raja, Salgia, Ravi, Kurzrock, Razelle, Meric-Bernstam, Funda, Hong, David S

Volltext

CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge von de Melo Gagliato, Debora, C Buzaid, Antonio, Perez-Garcia, Jose Manuel, Llombart, Antonio, Cortes, Javier

Volltext

The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer von Chae, Young Kwang, Gagliato, Debora de Melo, Pai, Sachin Gopalkrishna, Carneiro, Benedito, Mohindra, Nisha, Giles, Francis Joseph, Ramakrishnan-Geethakumari, Praveen, Sohn, Joohyuk, Liu, Shuying, Chen, Huiqin, Ueno, Naoto, Hortobagyi, Gabriel, Gonzalez-Angulo, Ana Maria

Volltext

Multigene Clinical Mutational Profiling of Breast Carcinoma Using Next-Generation Sequencing von Roy-Chowdhuri, Sinchita, de Melo Gagliato, Debora, Routbort, Mark J., Patel, Keyur P., Singh, Rajesh R., Broaddus, Russell, Lazar, Alexander J., Sahin, Aysegul, Alvarez, Ricardo H., Moulder, Stacy, Wheler, Jennifer J., Janku, Filip, Gonzalez-Angulo, Ana M., Chavez-MacGregor, Mariana, Valero, Vicente, Ueno, Naoto T., Mills, Gordon, Mendelsohn, John, Yao, Hui, Aldape, Kenneth, Luthra, Rajyalakshmi, Meric-Bernstam, Funda

Volltext

Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges von de Melo Gagliato, Debora, Buzaid, Antonio C., Perez-Garcia, Jose, Cortes, Javier

Volltext

Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer von de Melo Gagliato, Debora, Jardim, Denis Leonardo Fontes, Marchesi, Mario Sergio Pereira, Hortobagyi, Gabriel N

Volltext

Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer von DE MELO GAGLIATO, Debora, GONZALEZ-ANGULO, Ana M, XIUDONG LEI, THERIAULT, Richard L, GIORDANO, Sharon H, VALERO, Vicente, HORTOBAGYI, Gabriel N, CHAVEZ-MACGREGOR, Mariana

Volltext

Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice von de Melo Gagliato, Debora, Cortes, Javier, Curigliano, Giuseppe, Loi, Sherene, Denkert, Carsten, Perez-Garcia, Jose, Holgado, Esther

Volltext

Bevacizumab as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer: A Brazilian Center Experience von Jardim, Denis Leonardo Fontes, de Melo Gagliato, Débora, Ribeiro, Karina Braga, Shimada, Andrea Kazumi, Katz, Artur

Volltext

Clinical outcomes based on multigene profiling in metastatic breast cancer patients von Basho, Reva K, de Melo Gagliato, Debora, Ueno, Naoto T, Wathoo, Chetna, Chen, Huiqin, Shariati, Maryam, Wei, Caimiao, Alvarez, Ricardo H, Moulder, Stacy L, Sahin, Aysegul A, Roy-Chowdhuri, Sinchita, Chavez-MacGregor, Mariana, Litton, Jennifer K, Valero, Vincent, Luthra, Raja, Zeng, Jia, Shaw, Kenna R, Mendelsohn, John, Mills, Gordon B, Tripathy, Debu, Meric-Bernstam, Funda

Volltext

Biological therapies in breast cancer: Common toxicities and management strategies von Barroso-Sousa, Romualdo, Santana, Iuri A, Testa, Laura, de Melo Gagliato, Débora, Mano, Max S

Volltext

Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic von Tang, Chad, Hess, Kenneth, Jardim, Denis Leonardo F, Gagliato, Debora De Melo, Tsimberidou, Apostolia M, Falchook, Gerald, Fu, Siqing, Janku, Filip, Naing, Aung, Piha-Paul, Sarina, Subbiah, Vivek, Wheler, Jennifer, Zinner, Ralph G, Kurzrock, Razelle, Ellis, Lee M, Meric-Berstam, Funda, Hong, David S

Volltext

Noninvasive cancer biomarkers in solid malignancies: circulating tumor DNA-clinical utility, current limitations and future perspectives von de Melo Gagliato, Debora, Fontes Jardim, Denis L

Volltext